Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction

Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid... Eur J Plast Surg (2012) 35:317–319 DOI 10.1007/s00238-011-0570-5 CASE REPORT Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction Érika Malheiros Bastos & Rafael Denadai Pigozzi Silva Received: 7 October 2010 /Accepted: 7 March 2011 /Published online: 29 April 2011 Springer-Verlag 2011 Introduction observed. Here, we propose a new non-surgical procedure for the temporary treatment of congenital eyelid retraction Although eyelid retraction is the most common clinical based on botulinum toxin injections for the exophthalmos characteristic of Graves' ophthalmopathy [1, 2], congenital improvement in the Graves' disease. eyelid retraction is a relatively rare condition [3–5]. It can affect the upper eyelid, the lower eyelid or both [3, 6]. For the diagnosis, the upper eyelid on the affected side Case report should be above the limbus, with a difference of at least 0.5 mm between the upper levels of the upper eyelids on both A 27-year-old woman was referred to the surgery depart- sides [3, 5]. The presence of retraction from birth and ment presenting a history of eyelid asymmetry since she absence of other causes of eyelid retraction, such as trauma, was born. This was confirmed by childhood photographs. thyroid disease, proptosis, abnormalities of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Plastic Surgery Springer Journals

Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction

Loading next page...
 
/lp/springer_journal/injection-of-transcutaneous-botulinum-toxin-as-a-temporary-treatment-ecKroOqpeL

References (16)

Publisher
Springer Journals
Copyright
Copyright © 2012 by Springer-Verlag
Subject
Medicine & Public Health; Plastic Surgery
ISSN
0930-343X
eISSN
1435-0130
DOI
10.1007/s00238-011-0570-5
Publisher site
See Article on Publisher Site

Abstract

Eur J Plast Surg (2012) 35:317–319 DOI 10.1007/s00238-011-0570-5 CASE REPORT Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction Érika Malheiros Bastos & Rafael Denadai Pigozzi Silva Received: 7 October 2010 /Accepted: 7 March 2011 /Published online: 29 April 2011 Springer-Verlag 2011 Introduction observed. Here, we propose a new non-surgical procedure for the temporary treatment of congenital eyelid retraction Although eyelid retraction is the most common clinical based on botulinum toxin injections for the exophthalmos characteristic of Graves' ophthalmopathy [1, 2], congenital improvement in the Graves' disease. eyelid retraction is a relatively rare condition [3–5]. It can affect the upper eyelid, the lower eyelid or both [3, 6]. For the diagnosis, the upper eyelid on the affected side Case report should be above the limbus, with a difference of at least 0.5 mm between the upper levels of the upper eyelids on both A 27-year-old woman was referred to the surgery depart- sides [3, 5]. The presence of retraction from birth and ment presenting a history of eyelid asymmetry since she absence of other causes of eyelid retraction, such as trauma, was born. This was confirmed by childhood photographs. thyroid disease, proptosis, abnormalities of

Journal

European Journal of Plastic SurgerySpringer Journals

Published: Apr 1, 2012

There are no references for this article.